Leidos Faces Stock Pressure as Analyst Ratings Shift and Healthcare Sales Dip

Leidos Faces Stock Pressure as Analyst Ratings Shift and Healthcare Sales Dip

In recent weeks, Leidos Holdings Inc. (NYSE: LDOS) has experienced a notable decline in its stock price, influenced by analyst downgrades and challenges within its healthcare segment.

Analyst Downgrades Impact Stock Performance

On June 18, 2026, Bank of America downgraded Leidos from a “buy” to a “neutral” rating, reducing the price target from $200 to $125. This downgrade was primarily due to concerns over the company’s healthcare business performance. Following this announcement, Leidos’ stock price fell by 11% over the week, reaching a new 52-week low of $106.08.

Healthcare Segment Challenges

The healthcare division of Leidos has faced difficulties, particularly in its health and civil segment, which provides electronic health record systems to the Department of Defense and Veterans Affairs hospitals. In the fourth quarter of 2025, this segment reported a 9.3% decline in sales, contributing to the company’s overall revenue miss.

Acquisition of ENTRUST Solutions Group

In an effort to diversify and strengthen its portfolio, Leidos completed the acquisition of ENTRUST Solutions Group for approximately $2.4 billion in March 2026. This strategic move aims to enhance Leidos’ capabilities in energy infrastructure and grid modernization, potentially offsetting challenges in other segments.

Financial Performance and Outlook

Despite recent setbacks, Leidos reported strong first-quarter results in May 2026, with revenues of $4.2 billion, up 7% year-over-year, and net income of $365 million. The company also raised its full-year guidance, reflecting confidence in its strategic initiatives.

Conclusion

Leidos Holdings Inc. is navigating a complex landscape marked by analyst downgrades and challenges in its healthcare segment. However, strategic acquisitions and strong financial performance in other areas suggest potential for recovery and growth. Investors should monitor the company’s efforts to address these challenges and capitalize on new opportunities.